Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.14 Million SEK | 25.62% |
| 2022 | 12.05 Million SEK | -25.06% |
| 2021 | 16.08 Million SEK | 267.42% |
| 2020 | 4.37 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 10.83 Million SEK | 1.38% |
| 2024 Q1 | 10.68 Million SEK | -29.42% |
| 2023 Q3 | 13.82 Million SEK | -0.61% |
| 2023 FY | 15.14 Million SEK | 25.62% |
| 2023 Q1 | 13.42 Million SEK | 11.4% |
| 2023 Q2 | 13.91 Million SEK | 3.6% |
| 2023 Q4 | 15.14 Million SEK | 9.52% |
| 2022 Q3 | 12.95 Million SEK | -34.12% |
| 2022 Q4 | 12.05 Million SEK | -6.92% |
| 2022 FY | 12.05 Million SEK | -25.06% |
| 2022 Q2 | 19.65 Million SEK | 71.12% |
| 2022 Q1 | 11.48 Million SEK | -28.59% |
| 2021 Q1 | 5.55 Million SEK | 0.0% |
| 2021 FY | 16.08 Million SEK | 267.42% |
| 2021 Q2 | 23.73 Million SEK | 327.33% |
| 2021 Q4 | 16.08 Million SEK | -16.9% |
| 2021 Q3 | 19.35 Million SEK | -18.44% |
| 2020 FY | 4.37 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | 75.918% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 99.539% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 99.539% |
| Arcoma AB | 81.96 Million SEK | 81.523% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 97.782% |
| BICO Group AB (publ) | 10.19 Billion SEK | 99.851% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 97.994% |
| CellaVision AB (publ) | 928.71 Million SEK | 98.369% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | 73.765% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | 31.024% |
| C-Rad AB (publ) | 404 Million SEK | 96.251% |
| Dignitana AB (publ) | 44.83 Million SEK | 66.22% |
| Episurf Medical AB (publ) | 104.3 Million SEK | 85.48% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.973% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | 85.245% |
| Iconovo AB (publ) | 128.07 Million SEK | 88.176% |
| Integrum AB (publ) | 164.85 Million SEK | 90.814% |
| Luxbright AB (publ) | 40.68 Million SEK | 62.779% |
| Mentice AB (publ) | 322.52 Million SEK | 95.305% |
| OssDsign AB (publ) | 356.38 Million SEK | 95.751% |
| Paxman AB (publ) | 167.12 Million SEK | 90.939% |
| Promimic AB (publ) | 92.87 Million SEK | 83.694% |
| Qlife Holding AB (publ) | 39.04 Million SEK | 61.215% |
| SciBase Holding AB (publ) | 64.33 Million SEK | 76.46% |
| ScandiDos AB (publ) | 81.47 Million SEK | 81.412% |
| Sectra AB (publ) | 3.21 Billion SEK | 99.528% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 98.507% |
| Senzime AB (publ) | 433.54 Million SEK | 96.507% |
| SpectraCure AB (publ) | 144.83 Million SEK | 89.544% |
| Stille AB | 804.89 Million SEK | 98.119% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.908% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 99.31% |